Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kaufman

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Wounds : a Compendium of Clinical Research and Practice|March 9, 2017
Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover StudyCharles M Zelen, Dennis P Orgill, Thomas E Serena, et al.
The Journal of Urology|March 20, 2020
Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseaseWei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
Urology|August 12, 2020
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert InquiryKatharina Boehm, Anita Thomas, Axel Bex, et al.
Frontiers in Cardiovascular Medicine|July 16, 2021
Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL AmyloidosisAli M Agha, Nicolas Palaskas, Amit R Patel, et al.
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Wounds : a Compendium of Clinical Research and Practice|March 9, 2017
Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover StudyCharles M Zelen, Dennis P Orgill, Thomas E Serena, et al.
The Journal of Urology|March 20, 2020
Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseaseWei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
Urology|August 12, 2020
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert InquiryKatharina Boehm, Anita Thomas, Axel Bex, et al.
Frontiers in Cardiovascular Medicine|July 16, 2021
Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL AmyloidosisAli M Agha, Nicolas Palaskas, Amit R Patel, et al.
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Pageof 30